Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,769 total articles
Energy Fuels (UUUU) has been treated like a high-beta exploration name despite stepping into producer-like optionality across uranium and rare earth elements. With a market cap around $4.3B, tangible revenue potential, and a policy backdrop that favors domestic critical minerals, the risk/reward has shifted. We move from Hold to Buy with a clear en…
Exxon Mobil (XOM) looks like a pragmatic trade today: deep free cash flow, a conservative balance sheet, and direct exposure to higher oil prices. With crude volatile after renewed Iran tensions, this trade targets a re-test of $175 while capping risk below $152 over a mid-term 45 trading day window.
Microchip Technology (MCHP) is showing early signs of recovery after a deep multi-quarter correction. Revenue momentum, positive booking commentary and a sector-wide semiconductor rally have pushed the stock back above its short-term averages. For traders willing to take a measured risk, an entry near $65.60 with a $60 stop and a $78 target offers …
Stitch Fix is a cash-generating apparel subscription business trading at a sub-$500M market cap. With positive free cash flow, no debt, and technicals showing early bullish momentum, this is a tactical 'buy' for a swing trade sized modestly. Entry $3.35, stop $2.70, target $4.60.
Microsoft is 11% of my net asset value because the company sits at the intersection of cloud infrastructure, enterprise software and generative AI monetization. I lay out an actionable trade: enter at $460.00, stop at $380.00, target $690.00, with a 180-trading-day horizon. The idea leans on continued Azure share gains, expanding software ASPs from…
MTU Aero Engines (MTUAY) has pulled back from recent highs, offering a lower-risk entry into a high-quality engine OEM and MRO franchise. With a market cap near $19.7B, a P/E of ~17.6, improving technical momentum and structural tailwinds in engine MRO and next-gen propulsion, the risk/reward looks attractive for a mid-term swing trade.
Acuity Inc. reported another quarter of margin expansion and strong growth in its Acuity Intelligent Spaces segment, yet the stock has been punished on headline volatility. The company’s free cash flow ($534.5M), modest leverage (debt/equity 0.29) and ongoing buybacks create a rational basis to upgrade to a buy. This trade plan defines a precise en…
Anfield Energy (AEC) is a speculative, high-risk long trade for investors willing to back a micro-cap exposed to uranium assets and near-term permitting catalysts. With a market cap of roughly $88.5M, recent financings and a potential strategic relationship with Uranium Energy, the stock offers upside if permitting and project restarts proceed. But…
Workday (WDAY) plunged on cautious guidance, but the company's cash flow, net-dollar dynamics and early AI traction make the current pullback an asymmetric buying opportunity. Market cap near $34B, strong free cash flow ($2.78B), and expanding AI ARR (> $400M) argue for a swing trade with defined risk. Entry $128.00, stop $120.00, target $160.00 ov…
Bob's Discount Furniture has traded down sharply since its IPO-driven run, leaving the stock at a modest P/E (~12.8) and a market cap of about $1.46B while technicals show oversold conditions. With a stretched 52-week low of $10.20 and elevated options-implied moves, this is a tactical long setup for disciplined traders willing to stomach high vola…
Lumen's operational pivot toward AI-optimized fiber and on-demand networking is real, but the stock's next leg depends on whether the balance sheet can be tamed. With a market cap near $7.2B, EV of $23.8B, and modest free cash flow ($371M), the immediate trade is a risk-on long that sizes for volatility: entry at $6.75, stop at $5.75, target at $9.…
Novo Nordisk sits at the center of the GLP-1 obesity and diabetes boom. In a market effectively shared with one strong competitor, the company has the brand, scale, and margin profile to compound earnings. This trade idea offers a concrete entry, stop, and target with a long-term horizon and clear risk-management rules.
TSMC remains the primary beneficiary of hyperscaler AI spending. With ~$1.76T market cap, 60%+ gross margins and plans for $52-56B capex in 2026, the stock offers a favorable reward/risk for a long trade into $380 over the next 180 trading days. Entry, stop and target levels are explicit and justified by technicals, fundamentals and near-term catal…
Delek US has outperformed on a surge in refining crack spreads tied to tensions around the Strait of Hormuz. Q4 2025 showed a genuine operational turnaround, but the market is pricing a sustained, best-case geopolitical premium into the share price. We downgrade to a tactical short (neutral stance) to take advantage of a likely normalization or vol…
UiPath ($11.25) is trading roughly 40% below its 52-week high despite positive product progress into agentic AI orchestration, healthy free cash flow, and a sub-4x price-to-sales multiple. We lay out a long trade with entry, stop and target while weighing catalysts and the key execution risks that could keep growth muted.
UiPath is trading like a growth company that lost a step, but the fundamentals and product evolution argue for a tactical long. With ~13% revenue growth, positive free cash flow and a $5.9B market cap, PATH offers exposure to agentic AI orchestration at a modest multiple. This trade plan targets near-term re-rating catalysts while protecting capita…
Netflix is benefiting from price increases, an expanding ad business and fresh live-sports distribution that keep fundamentals healthy. The stock trades near $98.71 with solid technicals and meaningful free cash flow, making a tactical long trade appealing. That said, valuation is rich and consumer-sensitive revenue streams mean you should protect …
Nutrien (NTR) is a top North American fertilizer producer with a $36.3B market cap, trading near $75.48. Recent Middle East disruptions have tightened 30-35% of global fertilizer flows, creating an earnings and pricing tailwind for producers with domestic production and natural gas cost advantages. This trade idea outlines a tactical long into the …
Zoetis (ZTS) sits close to its 52-week low ($113.29) but its valuation remains elevated - P/E ~19.5, P/B ~15, EV ~$56.2B - despite slowing end-market growth and softness across key product segments. I propose a mid-term (45 trading days) short with a clear entry, stop, and target, sized for traders who can tolerate headline risk and wider moves in …
Chevron (CVX) is a conservative way to trade a market elevated oil risk premium from the Iran conflict. The company offers durable cash flow, a 3.5% yield, and a low leverage profile; combine that with oil supply shock dynamics and you get a mid-term trade worth executing around $198.67 with a $230 target and a $185 stop.
Vertex trades off recent weakness after a market pullback. With label expansions boosting chronic revenue streams for ALYFTREK and TRIKAFTA and a cash-generative foundation (free cash flow ~$3.19B, EPS $15.56), the setup favors a long trade sized for a medium-risk profile. Entry, stop and target provided with a clear horizon of 180 trading days.
Broadcom is uniquely positioned across chips, switching, and enterprise software to capture an AI infrastructure and services wave that is still in early innings. This trade idea outlines a long entry with concrete price levels, a multi-month horizon to let product cycles and large enterprise deals materialize, and a clear stop to control downside.
Duolingo is trading at a deeply discounted multiple after a messy pivot away from monetization toward user growth. With $1.04B in revenue, $414M in net income, a healthy free cash flow profile, and a plan to double daily active users to 100M by 2028, the risk/reward favors buyers. This trade idea outlines a disciplined entry at $97.19, a stop at $8…
Cogent (COGT) has clinical momentum: an accepted NDA for bezuclastinib in Non-Advanced Systemic Mastocytosis, robust SUMMIT efficacy signals, Breakthrough Therapy designation in GIST and a multi-NDA path in 2026. The shares trade at a premium - market cap roughly $5.6B - but the risk/reward supports a measured long position into upcoming regulatory…
Adeia has built a deep IP portfolio around hybrid bonding and 3D integration. Recent licensing wins (UMC), strong free cash flow ($156M annual), and accelerating adoption of chiplet architectures create a window for a medium-horizon long trade. Entry $24.87, target $32.00, stop $22.00. Time horizon: mid term (45 trading days).
